October 2022 | London, UK

Suzanne Randle

Senior Scientist - Oncology Safety Combinations
AstraZeneca
Suzanne Randle
Suzanne Randle is a cell biologist by training with extensive experience in a wide variety of cell culture models and techniques. She is currently part of the Oncology Safety team at AstraZeneca, specialising in in vitro models to help predict and mitigate haematological toxicity during oncology drug discovery and development. Prior to this she started her career working at the Mayo Clinic Jacksonville before getting her PhD from the University of Cambridge in 2012, focusing on the role of the ubiquitin ligase Fbxo7 in blood development, cancer, and Parkinsons disease. This was followed by academic postdocs at the University of Cambridge and Cambridge Institute for Medical Research, investigating phase separation in neuronal cells, before transitioning into industry.

Sessions

No data was found

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.